Detection of IL-1β, VEGF and IL-4 with their novel genetic variations in breast cancer patients

Interleukin-1β (IL-1β), vascular endothelial growth factor (VEGF), and IL-4 serum levels and new genetic mutations in breast cancer (BC) patients were assessed in the current study. The serum levels of the examined cytokines in 40 BC patients and 40 control subjects were assessed using the ELISA tec...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Tara Farooq, Qadir, Fikry Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812711/
https://www.ncbi.nlm.nih.gov/pubmed/36619680
http://dx.doi.org/10.1016/j.sjbs.2022.103544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812711/
https://www.ncbi.nlm.nih.gov/pubmed/36619680
http://dx.doi.org/10.1016/j.sjbs.2022.103544

Ejemplares similares